MPBS: ETM Pre Visit (15-45 Days) Task and Hold Bill Alerts (0-14 Days) Brown Bag
Activity Director: Demitra Kelly
Organization: MedStar Health System and Shared Services
ID: Od-036735
|
MPBS IDX INDIGO: ETM Claims Research Analyst/Claims Edits and Acknowledgement Rejections
Activity Director: Demitra Kelly
Organization: MedStar Health System and Shared Services
ID: Od-034766
|
MPBS IDX INDIGO: Pre Requisites for Track 6.7 Registration, Scheduling and Front Desk
Activity Director: Demitra Kelly
Organization: MedStar Health System and Shared Services
ID: Od-034122
|
Opioid/Substance Use Disorders CE: Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021.
Activity Director: John Yosaitis
Organization: MedStar Health System and Shared Services
ID: Od-035524
|
MedConnect Training for Radiation Therapists
Activity Director: Lydia Burke
Organization: MedStar Health System and Shared Services
ID: Od-032271
|
Opioid/Substance Use Disorders CE: The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.
Activity Director: John Yosaitis
Organization: MedStar Health System and Shared Services
ID: Od-035518
|
MHHC: Management of Chronic Illnesses Congestive Heart Failure and Chronic Obstructive Pulmonary Disease
Activity Director: Heather Fitzhugh-Boehm
Organization: MedStar Health Home Care
ID: Od-035715
|
MedConnect Training Video for Radiation Therapists
Faculty: Lydia Burke
Organization: MedStar Health System and Shared Services
ID: Pr-032270
|
June 2023 CE Quiz - Carbapenem resistance in Pseudomonas aeruginosa: An ongoing challenge for clinical laboratories
Faculty: Devon Wood
Organization: MedStar Washington Hospital Center
ID: Qu-035494
|
Opioid/Substance Use Disorders CE: Contingency Management for Patients Receiving Medication for Opioid Use Disorder.
Activity Director: John Yosaitis
Organization: MedStar Health System and Shared Services
ID: Od-035514
|
Opioid/Substance Use Disorders CE: Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.
Activity Director: John Yosaitis
Organization: MedStar Health System and Shared Services
ID: Od-035520
|
Opioid/Substance Use Disorders CE: Opioid Epidemic in the US Empirical Trends- Lit. Review of Social Determinants and Epidemiological, Pain Mgmt, and Treatment Patterns.
Activity Director: John Yosaitis
Organization: MedStar Health System and Shared Services
ID: Od-035522
|